Rakovina Therapeutics Inc. (TSX-V: RKV; FSE: 7JO0), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)-powered drug discovery, today announced the ...
Definium Therapeutics, Inc. (Nasdaq: DFTX) (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address the underlying ...
The Group sets out Six Major Leaps and five doubling targets, with RMB 600 billion in revenue and 1.5 million overseas sales in its sights for 2030. Changan Group held its Global Strategy Launch and ...
BlueFocus today released its 2025 annual report, reporting revenue of USD 10.07 billion, net profit of USD 32.984 million, net profit attributable to shareholders excluding non-recurring items of USD ...
Hydreight (HYDTF) has transformed into a 50-state healthcare infrastructure company, rapidly scaling VSDHOne licenses to 11K+ ...
SEOUL, South Korea, April 23, 2026 /PRNewswire/ -- Prestige Biopharma IDC, the innovative drug research institute of Prestige Biopharma, announced that it has filed a patent for 'IDC224,' a ...
Functional Brands Inc. (NASDAQ: MEHA), a leading innovator in wellness and performance products, today announced a strategic technology partnership ...
COSM READ THE FULL COSM RESEARCH REPORT Cosmos Health’s (NASDAQ: COSM) recent announcement of its rollout of its “18 Series” marks an important step in a shift away from traditional supplement ...
On April 17th, Han’s Laser (002008.SZ) released its 2025 annual report. The report indicates that Han’s Laser exceeded annual ...
The Dow Jones Industrial Average was established on May 26, 1896, as a straightforward benchmark to monitor market ...
In March, Pharmaceutical Executive reported on Eli Lilly’s efforts to push back against the availability of compounded GLP-1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results